β‘ This is your brand? Claim your page FREE and bring it to life on AI search.
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Dexoligo Therapeutics by Dexcel Pharma: RNA Oligonucleotides just got measured.
4/10 means Dexoligo Therapeutics by Dexcel Pharma: RNA Oligonucleotides is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
Our VisionWe believe that oligonucleotide drugs can improve the lives of patients, and address clinical needs unmet by other drug modalities.
Industry: Technology
dexoligo.com1
Structured Data
8
Content Structure
5
Entity Clarity
4
E-E-A-T Signals
6
Technical AEO
2
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
Tech buyers are the most research-intensive shoppers on the internet.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Dexoligo Therapeutics by Dexcel Pharma: RNA Oligonucleotides.
Scored by Engagemii on June 28, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/dexoligo
Cite this score: Engagemii (2026). "AEO Score for Dexoligo Therapeutics by Dexcel Pharma: RNA Oligonucleotides." Retrieved from https://engagemii.com/aeo/brands/dexoligo
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform